These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7964893)

  • 1. Peripheral iron metabolism in patients with Parkinson's disease.
    Cabrera-Valdivia F; Jiménez-Jiménez FJ; Molina JA; Férnandez-Calle P; Vázquez A; Cañizares-Liébana F; Larumbe-Lobalde S; Ayuso-Peralta L; Rabasa M; Codoceo R
    J Neurol Sci; 1994 Aug; 125(1):82-6. PubMed ID: 7964893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of ascorbic acid (vitamin C) in patients with Parkinson's disease.
    Férnandez-Calle P; Jiménez-Jiménez FJ; Molina JA; Cabrera-Valdivia F; Vázquez A; García Urra D; Bermejo F; Cruz Matallana M; Codoceo R
    J Neurol Sci; 1993 Aug; 118(1):25-8. PubMed ID: 8229047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of beta-carotene and other carotenoids in Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Fernández-Calle P; Vázquez A; Cabrera-Valdivia F; Catalán MJ; García-Albea E; Bermejo F; Codoceo R
    Neurosci Lett; 1993 Jul; 157(1):103-6. PubMed ID: 8233018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urinary manganese levels in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Aguilar MV; Arrieta FJ; Jorge-Santamaría A; Cabrera-Valdivia F; Ayuso-Peralta L; Rabasa M; Vázquez A; García-Albea E
    Acta Neurol Scand; 1995 May; 91(5):317-20. PubMed ID: 7639058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipid peroxides in patients with Parkinson's disease.
    Molina JA; Jiménez-Jiménez FJ; Fernandez-Calle P; Lalinde L; Tenias JM; Pondal M; Vazquez A; Codoceo R
    Neurosci Lett; 1992 Mar; 136(2):137-40. PubMed ID: 1641180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of inorganic sulfates in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Aguilar MV; Jorge-Santamaría A; Mateos-Vega CJ; González-Muñoz MJ; Cabrera-Valdivia F; Ayuso-Peralta L; Benito J; Vázquez A
    Acta Neurol Scand; 1995 Nov; 92(5):369-71. PubMed ID: 8610488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of zinc and copper in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Fernández-Calle P; Martínez-Vanaclocha M; Herrero E; Molina JA; Vázquez A; Codoceo R
    J Neurol Sci; 1992 Oct; 112(1-2):30-3. PubMed ID: 1469436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic iron metabolism and mortality from Parkinson's disease.
    Marder K; Logroscino G; Tang MX; Graziano J; Cote L; Louis E; Alfaro B; Mejia H; Slavkovich V; Mayeux R
    Neurology; 1998 Apr; 50(4):1138-40. PubMed ID: 9566409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of nitrates in patients with Parkinson's disease.
    Molina JA; Jiménez-Jiménez FJ; Navarro JA; Ruiz E; Arenas J; Cabrera-Valdivia F; Vázquez A; Fernández-Calle P; Ayuso-Peralta L; Rabasa M
    J Neurol Sci; 1994 Dec; 127(1):87-89. PubMed ID: 7699396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease.
    Férnandez-Calle P; Molina JA; Jiménez-Jiménez FJ; Vázquez A; Pondal M; García-Ruiz PJ; Urra DG; Domingo J; Codoceo R
    Neurology; 1992 May; 42(5):1064-6. PubMed ID: 1579230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of vitamin A in Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Fernández-Calle P; Vázquez A; Pondal M; del Ser T; Gómez-Pastor A; Codoceo R
    J Neurol Sci; 1992 Aug; 111(1):73-6. PubMed ID: 1403000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study].
    Molina-Arjona JA; de Bustos F; Benito-León J; Jiménez-Jiménez FJ; Rodríguez J; Trincado R; Porta-Etessan J; Vega S; Bermejo F
    Rev Neurol; 1999 Jul 1-15; 29(1):12-5. PubMed ID: 10528302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.
    Xu W; Zhi Y; Yuan Y; Zhang B; Shen Y; Zhang H; Zhang K; Xu Y
    J Neural Transm (Vienna); 2018 Jul; 125(7):1027-1032. PubMed ID: 29748849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum ferrokinetics in Parkinson's disease.
    Chen WH; Shih PY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):581-4. PubMed ID: 1296037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Aguilar MV; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Martínez-Salio A; Ortí-Pareja M; Zurdo M; Martínez-Para MC
    J Neural Transm (Vienna); 1998; 105(4-5):497-505. PubMed ID: 9720977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways.
    de Farias CC; Maes M; Bonifacio KL; Matsumoto AK; Bortolasci CC; Nogueira AS; Brinholi FF; Morimoto HK; de Melo LB; Moreira EG; Barbosa DS
    CNS Neurol Disord Drug Targets; 2017; 16(4):484-491. PubMed ID: 28240188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.
    Deng Q; Zhou X; Chen J; Pan M; Gao H; Zhou J; Wang D; Chen Q; Zhang X; Wang Q; Xu Y
    Brain Res; 2017 Jan; 1655():145-151. PubMed ID: 27840188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Si QQ; Yuan YS; Zhi Y; Tong Q; Zhang L; Zhang K
    Neurosci Lett; 2018 Sep; 684():42-46. PubMed ID: 29981876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered systemic iron metabolism in Parkinson's disease.
    Logroscino G; Marder K; Graziano J; Freyer G; Slavkovich V; LoIacono N; Cote L; Mayeux R
    Neurology; 1997 Sep; 49(3):714-7. PubMed ID: 9305329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.